C13H15FO3
238.25 g/mol
의약 중간체위험
((1R, 2S)-2-(3-Fluorophenyl)-2-(Hydroxymethyl)Cyclopropyl) Methyl Acetate
CAS1369768-29-5EC857-049-3
용도 분류
의약 중간체
화합물 분류
에스터
주요 용도
의약 중간체
This compound is a chiral cyclopropylmethyl acetate derivative featuring a fluorophenyl substituent and a primary alcohol group. It is used as a pharmaceutical intermediate in chemical synthesis.
pharmaceutical intermediate
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 1369768-29-5
관련 화합물
참고동일 카테고리
2-[(2S)-2-Hydroxy-3-[[4-(3-oxo-4-morpholinyl)phenyl]amino]propyl]-1H-isoindole-1,3(2H)-dione
CAS1369969-44-7
pharmaceutical intermediate
참고동일 카테고리
4-(Dibenzo[b,d]thiophen-4-yl)aniline
CAS1370034-50-6
pharmaceutical intermediate
참고동일 카테고리
7-(Benzyloxy)-3,4,12,12a-tetrahydro-1H-[1,4]oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione
CAS1370250-39-7
Pharmaceutical intermediate for baloxavir marboxil
참고동일 카테고리
Tert-butyl 4-formylpiperidine-1-carboxylate
CAS137076-22-3
pharmaceutical intermediate
참고same scaffold
((1S, 2R)-1-(3-Fluorophenyl) Cyclopropane-1,2-diyl) Dimethanol
CAS1369767-20-3
pharmaceutical intermediate
참고same scaffold
4-(2,2-Dichlorocyclopropyl)phenyl acetate
CAS144900-34-5
active pharmaceutical ingredient
참고same scaffold
LEVOMILNACIPRAN HYDROCHLORIDE
CAS175131-60-9
active pharmaceutical ingredient
참고same scaffold
(1R,2R)-2-(3,4-Difluorophenyl)cyclopropanecarboxylic acid
CAS220352-36-3
Ramelteon intermediate
안전 참조
위험
H302Harmful if swallowed
H311Toxic in contact with skin
H314Causes severe skin burns and eye damage
H318Causes serious eye damage
H401Toxic to aquatic life
H411Toxic to aquatic life with long lasting effects
식별자
IUPAC 이름
[(1R,2S)-2-(3-fluorophenyl)-2-(hydroxymethyl)cyclopropyl]methyl acetate
InChIKey
VXNBTSLXRMFPQE-WCQYABFASA-N
SMILES
CC(=O)OC[C@@H]1C[C@@]1(CO)C2=CC(=CC=C2)F
동의어 목록 (1)
—